Gregory Norden sold $1.2M of Royalty Pharma (RPRX)

Executed Aug 11 2025, disclosed Aug 11 2025, the same day.

Value, as filed

$1.2M

33,500 sh × $36.23

Executed

Aug 11 2025

the trade date, as filed

Disclosed

Aug 11 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Gregory Norden Director profile →

Gregory Norden (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Royalty Pharma plc (RPRX). The largest single filing was $161K of RPRX (3,045 sh × $53.00, as filed), executed May 14.

The name

RPRX

Royalty Pharma plc RPRX · Healthcare · 36 filings in 24 months ticker →

Healthcare · Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the U…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Gregory Norden in RPRX

RPRXSALE Royalty Pharma plc $161K
3,045 sh × $53.00
Exec May 14
Filed May 15 · 5:30 PM ET